Jumar Bioincubator
AcceleratorMelbourne · Pre-Seed–Series A · 9 people tracked
Find your way into Jumar Bioincubator
615 people in our graph share verified history with the Jumar Bioincubator team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Jumar Bioincubator aims to build a critical mass of scientist-entrepreneurs across Australia and the region by giving early-stage biotech and medtech ventures a first home with the practical support needed to overcome early commercialisation challenges. Established by CSL, WEHI and the University of Melbourne, with backing from Breakthrough Victoria and operated by Cicada Innovations, it focuses on connecting biopharma and medtech startups to facilities, programs, events and ecosystem networks. The goal is to steward a thriving biotechnology ecosystem that turns world-class research into real-world health outcomes and lasting economic and social impact.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website & curatedFrequently asked questions
- What stage does Jumar Bioincubator invest at?
- Jumar Bioincubator invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Jumar Bioincubator focus on?
- Jumar Bioincubator focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
- Where is Jumar Bioincubator located?
- Jumar Bioincubator is headquartered in Melbourne, AU.
Similar investors
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Sunstone Life Science Ventures is an independent European venture capital firm focused on early-stage life science companies developing novel therapeutics for humans.
Mission BioCapital provides early-stage capital and shared lab space to life science entrepreneurs, supporting companies from idea through clinic and exit.
Research Corporation Technologies (RCT) develops and invests in biomedical technologies, providing venture capital through its RCT Ventures program to start-up and early-stage companies with life science and therapeutic/diagnostic products.








